Highlights

[PUC] YoY Quarter Result on 2020-06-30 [#2]

Stock [PUC]: PUC BHD
Announcement Date 26-Aug-2020
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2020
Quarter 30-Jun-2020  [#2]
Profit Trend QoQ -     12.97%    YoY -     -326.23%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 1,426 17,639 16,453 10,127 5,088 7,244 11,707 -29.57%
  YoY % -91.92% 7.21% 62.47% 99.04% -29.76% -38.12% -
  Horiz. % 12.18% 150.67% 140.54% 86.50% 43.46% 61.88% 100.00%
PBT -5,975 2,664 2,341 421 496 416 1,216 -
  YoY % -324.29% 13.80% 456.06% -15.12% 19.23% -65.79% -
  Horiz. % -491.37% 219.08% 192.52% 34.62% 40.79% 34.21% 100.00%
Tax 16 -30 -19 0 0 0 -127 -
  YoY % 153.33% -57.89% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % -12.60% 23.62% 14.96% -0.00% -0.00% -0.00% 100.00%
NP -5,959 2,634 2,322 421 496 416 1,089 -
  YoY % -326.23% 13.44% 451.54% -15.12% 19.23% -61.80% -
  Horiz. % -547.20% 241.87% 213.22% 38.66% 45.55% 38.20% 100.00%
NP to SH -5,959 2,634 2,322 417 497 447 1,102 -
  YoY % -326.23% 13.44% 456.83% -16.10% 11.19% -59.44% -
  Horiz. % -540.74% 239.02% 210.71% 37.84% 45.10% 40.56% 100.00%
Tax Rate - % 1.13 % 0.81 % - % - % - % 10.44 % -
  YoY % 0.00% 39.51% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 10.82% 7.76% 0.00% 0.00% 0.00% 100.00%
Total Cost 7,385 15,005 14,131 9,706 4,592 6,828 10,618 -5.87%
  YoY % -50.78% 6.18% 45.59% 111.37% -32.75% -35.69% -
  Horiz. % 69.55% 141.32% 133.09% 91.41% 43.25% 64.31% 100.00%
Net Worth 194,259 252,071 199,003 159,919 155,262 133,541 10,791,123 -48.77%
  YoY % -22.93% 26.67% 24.44% 3.00% 16.27% -98.76% -
  Horiz. % 1.80% 2.34% 1.84% 1.48% 1.44% 1.24% 100.00%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 194,259 252,071 199,003 159,919 155,262 133,541 10,791,123 -48.77%
  YoY % -22.93% 26.67% 24.44% 3.00% 16.27% -98.76% -
  Horiz. % 1.80% 2.34% 1.84% 1.48% 1.44% 1.24% 100.00%
NOSH 474,730 2,116,471 1,513,334 1,042,500 993,999 1,117,500 847,692 -9.20%
  YoY % -77.57% 39.85% 45.16% 4.88% -11.05% 31.83% -
  Horiz. % 56.00% 249.67% 178.52% 122.98% 117.26% 131.83% 100.00%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -417.88 % 14.93 % 14.11 % 4.16 % 9.75 % 5.74 % 9.30 % -
  YoY % -2,898.93% 5.81% 239.18% -57.33% 69.86% -38.28% -
  Horiz. % -4,493.33% 160.54% 151.72% 44.73% 104.84% 61.72% 100.00%
ROE -3.07 % 1.04 % 1.17 % 0.26 % 0.32 % 0.33 % 0.01 % -
  YoY % -395.19% -11.11% 350.00% -18.75% -3.03% 3,200.00% -
  Horiz. % -30,700.00% 10,400.00% 11,700.00% 2,600.00% 3,200.00% 3,300.00% 100.00%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 0.30 0.83 1.09 0.97 0.51 0.65 1.38 -22.44%
  YoY % -63.86% -23.85% 12.37% 90.20% -21.54% -52.90% -
  Horiz. % 21.74% 60.14% 78.99% 70.29% 36.96% 47.10% 100.00%
EPS -1.26 0.12 0.15 0.04 0.05 0.04 0.13 -
  YoY % -1,150.00% -20.00% 275.00% -20.00% 25.00% -69.23% -
  Horiz. % -969.23% 92.31% 115.38% 30.77% 38.46% 30.77% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.4092 0.1191 0.1315 0.1534 0.1562 0.1195 12.7300 -43.58%
  YoY % 243.58% -9.43% -14.28% -1.79% 30.71% -99.06% -
  Horiz. % 3.21% 0.94% 1.03% 1.21% 1.23% 0.94% 100.00%
Adjusted Per Share Value based on latest NOSH - 617,147
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 0.23 2.86 2.67 1.64 0.82 1.17 1.90 -29.64%
  YoY % -91.96% 7.12% 62.80% 100.00% -29.91% -38.42% -
  Horiz. % 12.11% 150.53% 140.53% 86.32% 43.16% 61.58% 100.00%
EPS -0.97 0.43 0.38 0.07 0.08 0.07 0.18 -
  YoY % -325.58% 13.16% 442.86% -12.50% 14.29% -61.11% -
  Horiz. % -538.89% 238.89% 211.11% 38.89% 44.44% 38.89% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.3148 0.4084 0.3225 0.2591 0.2516 0.2164 17.4855 -48.77%
  YoY % -22.92% 26.64% 24.47% 2.98% 16.27% -98.76% -
  Horiz. % 1.80% 2.34% 1.84% 1.48% 1.44% 1.24% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 0.1400 0.0650 0.1900 0.1400 0.0700 0.1250 0.1850 -
P/RPS 46.61 7.80 17.48 14.41 13.68 19.28 13.40 23.07%
  YoY % 497.56% -55.38% 21.30% 5.34% -29.05% 43.88% -
  Horiz. % 347.84% 58.21% 130.45% 107.54% 102.09% 143.88% 100.00%
P/EPS -11.15 52.23 123.83 350.00 140.00 312.50 142.31 -
  YoY % -121.35% -57.82% -64.62% 150.00% -55.20% 119.59% -
  Horiz. % -7.84% 36.70% 87.01% 245.94% 98.38% 219.59% 100.00%
EY -8.97 1.91 0.81 0.29 0.71 0.32 0.70 -
  YoY % -569.63% 135.80% 179.31% -59.15% 121.88% -54.29% -
  Horiz. % -1,281.43% 272.86% 115.71% 41.43% 101.43% 45.71% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.34 0.55 1.44 0.91 0.45 1.05 0.01 79.89%
  YoY % -38.18% -61.81% 58.24% 102.22% -57.14% 10,400.00% -
  Horiz. % 3,400.00% 5,500.00% 14,400.00% 9,100.00% 4,500.00% 10,500.00% 100.00%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 26/08/20 28/08/19 30/08/18 25/08/17 26/08/16 28/08/15 28/08/14 -
Price 0.3000 0.0700 0.1650 0.1300 0.0650 0.0850 0.2350 -
P/RPS 99.87 8.40 15.18 13.38 12.70 13.11 17.02 34.26%
  YoY % 1,088.93% -44.66% 13.45% 5.35% -3.13% -22.97% -
  Horiz. % 586.78% 49.35% 89.19% 78.61% 74.62% 77.03% 100.00%
P/EPS -23.90 56.25 107.54 325.00 130.00 212.50 180.77 -
  YoY % -142.49% -47.69% -66.91% 150.00% -38.82% 17.55% -
  Horiz. % -13.22% 31.12% 59.49% 179.79% 71.91% 117.55% 100.00%
EY -4.18 1.78 0.93 0.31 0.77 0.47 0.55 -
  YoY % -334.83% 91.40% 200.00% -59.74% 63.83% -14.55% -
  Horiz. % -760.00% 323.64% 169.09% 56.36% 140.00% 85.45% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.73 0.59 1.25 0.85 0.42 0.71 0.02 82.03%
  YoY % 23.73% -52.80% 47.06% 102.38% -40.85% 3,450.00% -
  Horiz. % 3,650.00% 2,950.00% 6,250.00% 4,250.00% 2,100.00% 3,550.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

2170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCOMNET 2.300.00 
 KOTRA 3.180.00 
 UCREST 0.140.00 
 GENM-C73 0.0050.00 
 PUC 0.240.00 
 WILLOW 0.4250.00 
 EAH-WE 0.0150.00 
 IRIS 0.260.00 
 TOPGLOV-C79 0.4150.00 
 BTECH 0.4550.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
3. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS